Gland Pharma Limited (NSE: GLAND) reports record revenues and profitability with 22% YoY growth in Q4 FY26 and 97% PAT growth.
Skipper Limited (SKIPPER) secures fresh new orders worth Rs 1,265 crores for several domestic and international T&D projects.
Lupin Limited (LUPIN) inaugurates Atharv Ability, a state-of-the-art neuro-rehabilitation center in Delhi, expanding access to advanced care for neurological disorders.
Pearl Global Industries Limited (PGIL) reports record FY26 results with revenue crossing ₹5,000 crore and installed capacity surpassing 100 million pieces.
P N Gadgil Jewellers Limited (PNGJL) reports record FY26 revenue of ₹1,07,391 Mn, with PAT growing 87.8% YoY. Key highlights include strong retail and franchise growth.
Dwarikesh Sugar Industries Limited (DWARKESH) reports Q4 FY26 PAT up 24% to ₹57.41 crore, despite lower sugar production.
Aeroflex Enterprises Limited (AEROENTER) reports record revenue growth and strategic divestment in Q4 & FY26, marking strong performance.
Max Financial Services Limited (MFSL) reports 19% YoY growth in Individual Adjusted First Year Premium for FY’26, driven by Axis Max Life’s strong performance.
MTAR Technologies Limited announces Q4 FY26 results with revenue up 67.2% and EBITDA growth of 80.9%.
Cohance Lifesciences Limited (COHANCE) reports FY26 Q4 results, showcasing strategic growth alignment and a transition year outlook for FY27.